"At Baylor Scott & White Research Institute, you are at the heart of everything we do. This philosophy extends to our research, where we focus on breakthroughs that mean something to you—a more accurate diagnosis, a faster recovery or a more effective treatment. Our research brings innovation from our laboratory to your bedside."

During the past decade, Baylor Research Center-Site Number:840058 conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Baylor Research Center-Site Number:840058" are "Cerebroside Lipidosis Syndrome" (1 trials), "Fabry Disease" (1 trials), "Gaucher Disease" (1 trials), "Glucocerebrosidase Deficiency Disease" (1 trials) and "Glucosylceramide Beta-Glucosidase Deficiency Disease" (1 trials). Many other conditions were trialed in "Baylor Research Center-Site Number:840058" in a lesser frequency.

The vast majority of trials in "Baylor Research Center-Site Number:840058" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Baylor Research Center-Site Number:840058". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Baylor Research Center-Site Number:840058, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Baylor Research Center-Site Number:840058, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".